Oxycodone Hydrochloride
Pricing Report NDC 0115-1561-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Oxycodone Hydrochloride (NDC 0115-1561-01) is $9.61352 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 22, 2018.

As a provided by Amneal Pharmaceuticals Of New York Llc, this medication is distributed in a 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.61352
Per EA

Effective Date
Aug 22, 2018
Billable Units
100 EA
Estimated Package Price
$961.35
Data Status
As of Aug 14, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2016, the NADAC wholesale price for (NDC ) has moved within a range of $9.25294 to $10.08030 per EA. Over this 2 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.2529 - $10.0803
Market Volatility
8.94% Variance
Latest Trend
0.98%
Date Unit Price Unit Source Method Rate
Aug 22, 2018 $9.61352 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $9.61352 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 23, 2018 $9.70868 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $9.70868 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 20, 2017 $9.26273 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2017 $9.26273 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 23, 2017 $9.25294 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 19, 2017 $9.37137 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 23, 2016 $9.30228 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 23, 2016 $9.30228 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 19, 2016 $10.08030 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2016 $9.92858 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2016 $9.92858 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 20, 2016 $9.76697 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2016 $9.79663 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026